Advanced search
Publication Cover
Current Medical Research and Opinion Volume 23, 2007 - Issue 6
Submit an article Journal homepage
218
Views
14
CrossRef citations to date
0
Altmetric
Original Article

Will insomnia treatments produce overall cost savings to commercial managed-care plans? A predictive analysis in the United States

M. Jhaveri Rutgers Pharmacoeconomics and Health Outcomes Fellow, Piscataway, NJ, USA
,
B. Seal Health Outcomes, sanofi-aventis, Bridgewater, NJ, USA
,
M. Pollack Research Development & Operations, HealthCore, Wilmington, DE, USACorrespondence[email protected]
&
D. Wertz Research Development & Operations, HealthCore, Wilmington, DE, USA
Pages 1431-1443 | Accepted 18 Apr 2007, Published online: 17 May 2007

Citations (14)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (1)

Michael D Lemon, Joe D Strain, Annie M Hegg & Debra K Farver. (2009) Indiplon in the management of insomnia. Drug Design, Development and Therapy 3, pages 131-142.
Read now

Articles from other publishers (13)

Makoto Uchiyama, Kaoru Ito, Yasuyuki Okumura, Jingbo Yi, Bruce Crawford & Machiko Abe. (2022) Medical Costs Associated with Insomnia Treatment with Suvorexant Monotherapy in Japan: Results from a Retrospective Cohort Study Using a Large-Scale Claims Database. Drugs - Real World Outcomes 9:2, pages 219-229.
Crossref
Hrishikesh P. Kale, Zaina P. Qureshi, Ruchit Shah, Rezaul Khandker, Marc Botteman, Weilin Meng & Ruth Benca. (2021) Changes in Healthcare Resource Use and Costs in Commercially Insured Insomnia Patients Initiating Suvorexant. Advances in Therapy 38:10, pages 5221-5237.
Crossref
Philip Cheng, Melynda D Casement, David A Kalmbach, Andrea Cuamatzi Castelan & Christopher L Drake. (2021) Digital cognitive behavioral therapy for insomnia promotes later health resilience during the coronavirus disease 19 (COVID-19) pandemic. Sleep 44:4.
Crossref
Daniel F. Kripke. (2017) What do hypnotics cost hospitals and healthcare?. F1000Research 6, pages 542.
Crossref
Emerson M. Wickwire, Fadia T. Shaya & Steven M. Scharf. (2016) Health economics of insomnia treatments: The return on investment for a good night's sleep. Sleep Medicine Reviews 30, pages 72-82.
Crossref
X.-l. Jiang, X.-y. Zheng, J. Yang, C.-p. Ye, Y.-y. Chen, Z.-g. Zhang & Z.-j. Xiao. (2015) A systematic review of studies on the prevalence of Insomnia in university students. Public Health 129:12, pages 1579-1584.
Crossref
J. Zeitlhofer, S. Seidel, G. Klösch, D. Moser, P. Anderer, I.H. Machatschke, J. Bolitschek, B. Fugger, B. Holzinger, R. Kerbl, M. Lehofer, W. Mallin, R. Pavelka, R. Popovic, A. Saletu, B. Saletu & B. Högl. (2010) Die Schlafgewohnheiten der ÖsterreicherSleep habits in Austrians. Somnologie - Schlafforschung und Schlafmedizin 14:1, pages 6-14.
Crossref
Francois Dionne, Craig Mitton, Jean Shoveller, Stuart Peacock & Morris Barer. (2009) How to Control the Costs of Health Care Services — An Inventory of Strategic Options. Healthcare Management Forum 22:4, pages 23-30.
Crossref
Marc Botteman. (2009) Health economics of insomnia therapy: Implications for policy. Sleep Medicine 10, pages S22-S25.
Crossref
Anna K. Morin & Kristine Willett. (2009) The role of eszopiclone in the treatment of insomnia. Advances in Therapy 26:5, pages 500-518.
Crossref
Natalie D. Dautovich, Jacob M. Williams & Christina S. McCrae. (2009) Insomnia: A Review of the Use of Eszopiclone. Clinical Medicine. Therapeutics 1, pages CMT.S1940.
Crossref
Katsuhisa Banno & Meir H. Kryger. (2008) The Circuitous Route to Diagnosing Sleep Disorders in Women: Health Care Utilization and Benefits of Improved Awareness for Sleep Disorders. Sleep Medicine Clinics 3:1, pages 133-140.
Crossref
Dene Simpson & Monique P Curran. (2008) Ramelteon. Drugs 68:13, pages 1901-1919.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.